NCT01837186

Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)

Incidence, Risk Factors and Outcome of Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 600 (actual)
• Sponsor: University Hospital, Gasthuisberg · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Empyema following pneumonectomy for Non Small Cell Lung Cancer (NSCLC) is a known problem that occurs in about 2% of pneumonectomy patients.

Detailed description

The development of an empyema following pneumonectomy is a devastating complication, especially if associated with an underlying fistula. Whilst the perioperative mortality of pneumonectomy overall is now less than 5%, this rises to around 25% when complicated by empyema, and about 50% when associated with fistula. In addition, there is the morbidity and social cost of long-term drainage, chronic sepsis and often multiple operations.

Conditions

• Non Small Cell Lung Cancer
• Lung Cancer

Timeline

• Start date: 2012-01-01
• Primary completion: 2012-09-01
• Completion: 2013-03-01
• First posted: 2013-04-23
• Last updated: 2013-04-23

Locations

1 site across 1 country: Belgium